Liposomal vs Standard Supplements: What’s the Difference?
From delivery and cost to manufacturing complexity and brand positioning, liposomes are unique.
From delivery and cost to manufacturing complexity and brand positioning, liposomes are unique.

The supplement industry is evolving. Brands and consumers now look beyond ingredients, focusing on delivery systems, absorption, and manufacturing quality.
That’s where the conversation around liposomal versus standard supplements gets interesting.
Both formats work well, but the way they are manufactured and what that means at scale is very different.
This guide walks through those differences from a practical, manufacturing-first perspective.
Let’s go.
At first glance, supplement formats may seem similar. Powders are blended. Capsules are filled. Bottles are labeled.
Simple, right?
However, liposomal manufacturing is a bit more complex…
We’re engineering a liquid delivery system capable of encapsulating active ingredients that don’t want to be enveloped by water. And it’s not easy.
To get it right, we have to control phospholipid hydration, use high-shear homogenization, precisely optimize particle size, and manage oxidation conditions – all while developing a product with a long shelf life.
Even minor process variations can affect vesicle integrity and supplement performance.
In short? Liposomal supplements aren’t for the faint of heart, and definitely require a reputable manufacturing partner to get right.
Standard supplements may be easier to work with, but there are good reasons to choose a liposome delivery mechanism over more common techniques.
In fairness, liposomes aren’t right for every ingredient or supplement.
Water-soluble substances need to be evaluated to determine how effective they really are. Liposomes carry stories that can resonate with consumers, but it’s best to back your formulation with evidence it’s actually meaningful.
Figuring out how to scale sounds like a good problem. Right?
With standard supplements, growth often means bigger machines, more product, and a bit more time. (If a facility can produce 2,000 units, moving to 20,000 is typically operationally manageable.)
But liposomal manufacturing is different.
As batch sizes increase:
In other words, what works for pilot runs won’t necessarily work for commercial-scale quantities. Complicated process controls, oxygen management strategies, and engineering infrastructure have to be in place in order to succeed at scale.
Quality control for standard supplements includes verifying ingredients, checking potency, microbial testing, and stability studies.
Liposomal supplements, however, add another layer to that process: validating the structure itself. And at commercial scale, even small deviations can impact vesicle integrity, uniformity, and overall performance.
Key areas of focus include:
In general, liposomal supplements can cost 20-50% more than their standard counterparts, and the cost difference isn't arbitrary.
We’re handling:
However, the benefits can outweigh the costs for the right product. Between premium positioning and sometimes lower raw ingredient costs, the numbers may justify choosing liposomes over other delivery formats.
As you scale, success hinges on choosing the right partner.
Here are key traits to look for during due diligence.
Commercial Scale Experience: Look for manufacturers with documented large-batch liposomal runs, not just lab-scale trials. Also, make sure they are FDA-registered and maintain cGMP compliance.
Liposomal Track Record: Work with a manufacturer with a validated liposomal process.
Scalability: Many brands learn that their manufacturer can’t keep up with growth just as they really start to get traction. This is a worst-case scenario. Instead, start with a partner who can meet you where you are and grow with you as you succeed.
Are you exploring a liposomal supplement launch?
When the time is right, reach out for a free consultation. We’ll talk goals, vision, and how we can help get you there.
Ben Steuart — Owner, Steuart Nutrition

Ben Steuart is the co-founder and CEO of Steuart Nutrition, a contract manufacturing and supplement innovation partner for powder, liquid, and stick‑pack supplements. He launched the company in 2019 alongside his wife, Sarah, building on his lifelong roots in the food production industry, where he grew up working in his father's manufacturing business in Mabel, Minnesota.
Throughout his career, Ben has developed deep expertise in supplement manufacturing and business operations. At Steuart, he leads with a commitment to lean operations, fostering long-term partnerships, and delivering flexible, transparent service—prioritizing the client’s vision as much as his own. His leadership guided the business’s rapid expansion from a single facility to multiple locations, enabling agile responses to market needs—from producing hand sanitizer during the COVID‑19 pandemic to scaling CBD and nutrition supplement lines.
Your Brand Deserves a Manufacturing Partner That Scales With You.